PrEP Access and Coverage Act of 2026
Increase access to pre-exposure prophylaxis (PrEP) to reduce the transmission of HIV.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
GovInfo lists H.R. 7853 as introduced March 5, 2026, with Mark Pocan as a named House cosponsor. The bill's full title is to increase access to pre-exposure prophylaxis to reduce HIV transmission, and its listed action is referral to multiple House committees.
legacy_unverified · Source version not recorded · locator unknown
CMS states that, as of September 30, 2024, Medicare covers FDA-approved PrEP drugs, injectable PrEP administration, supplying or dispensing, counseling, HIV screenings, and hepatitis B screening without Part B cost-sharing for eligible people with Medicare.
Assessments
Pocan cosponsored H.R. 7853, the PrEP Access and Coverage Act of 2026, which directly matches the promise but remained at introduction/referral and was not enacted. CMS separately expanded Medicare PrEP coverage without Part B cost-sharing as of September 30, 2024, which partially increased access, but the evidence does not show Pocan delivered or materially caused that administrative outcome. This supports partial fulfillment with credit for a serious legislative effort during his federal term, not full delivery.